Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial

Схожие документы

• Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial
  по: Fichtenbaum, Carl J, et al.
  Опубликовано: (2020)
• Rationale and Design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) RCT# NCT02344290
  по: Grinspoon, Steven K., et al.
  Опубликовано: (2019)
• Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum
  по: Smeaton, Laura M, et al.
  Опубликовано: (2020)
• Rationale and design of the Mechanistic Substudy of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE): Effects of pitavastatin on coronary artery disease and inflammatory biomarkers
  по: Hoffmann, Udo, et al.
  Опубликовано: (2019)
• Successful recruitment of a multi-site international randomized placebo-controlled trial in people with HIV with attention to diversity of race and ethnicity: Critical role of central coordination
  по: Fitch, Kathleen V., et al.
  Опубликовано: (2020)